Alan Ashworth

Advisor at Earli

Alan Ashworth is the President of the UCSF Helen Diller Family Comprehensive Cancer Center, and the Sr. Vice President for Cancer Services with UCSF Health. He was on the team that identified the BRCA2 breast cancer susceptibility gene, and a decade later, discovered how to kill related tumor cells with PARP inhibitors. Four different PARP inhibitors have now been approved by the FDA for the treatment of ovarian, breast, pancreatic and prostate cancer based on his work. Beyond driving serious progress, Alan prefers to stay on the British-humorous side, with a cat at home named Jonesy after the cat in the film Alien.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Earli

1 followers

Earli has an ambitious mission: to force cancer reveal its location at its earliest stages, which makes it quickly treatable. In other words, they aim to make cancer a benign experience. Their science is based on a new method of detecting, localizing and then treating cancer called "Synthetic Biopsies," originally developed by the late Dr. Sam Gambhir at Stanford.


Industries

Employees

11-50

Links